Piero Vincenzo Lippolis
Overview
Explore the profile of Piero Vincenzo Lippolis including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
24
Citations
55
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Salani F, Vivaldi C, Rreka E, Genovesi V, Masi G, Lippolis P, et al.
J Clin Oncol
. 2024 Mar;
42(15):1861-1862.
PMID: 38484188
No abstract available.
2.
Tonello M, Baratti D, Sammartino P, Di Giorgio A, Robella M, Sassaroli C, et al.
Eur J Surg Oncol
. 2024 Mar;
49(3):604-610.
PMID: 38432873
Introduction: The selection of patients undergoing cytoreductive- surgery (CRS) followed by hyperthermic intraperitoneal chemotherapy (HIPEC) is crucial. BIOSCOPE and COMPASS are prognostic scores designed to stratify survival into four classes...
3.
Rossetti M, Stanca S, Del Frate R, Bartoli F, Marciano A, Esposito E, et al.
Diagnostics (Basel)
. 2023 Oct;
13(20).
PMID: 37892020
In 2020, the Global Cancer Observatory estimated the incidence of colorectal cancer (CRC) at around 10.7% coupled with a mortality rate of 9.5%. The explanation for these values lies in...
4.
Tonello M, Baratti D, Sammartino P, Di Giorgio A, Robella M, Sassaroli C, et al.
Ann Surg Oncol
. 2023 Oct;
31(1):594-604.
PMID: 37831280
Purpose: Multimodal treatment of colorectal (CRC) peritoneal metastases (PM) includes systemic chemotherapy (SC) and surgical cytoreduction (CRS), eventually with hyperthermic intraperitoneal chemotherapy (HIPEC), in select patients. Considering lack of clear...
5.
Gambaccini D, Ruggiero L, Lippolis P, Marciano E
J Gastrointestin Liver Dis
. 2023 Jun;
32(2):265-266.
PMID: 37345606
No abstract available.
6.
Robella M, Tonello M, Berchialla P, Sciannameo V, Ilari Civit A, Sommariva A, et al.
Cancers (Basel)
. 2023 Feb;
15(3).
PMID: 36765534
Enhanced recovery after surgery (ERAS) program refers to a multimodal intervention to reduce the length of stay and postoperative complications; it has been effective in different kinds of major surgery...
7.
Carboni F, Valle M, Vaira M, Sammartino P, Federici O, Robella M, et al.
Cancers (Basel)
. 2022 Dec;
14(23).
PMID: 36497306
Background: Cytoreductive surgery with hyperthermic intraperitoneal chemotherapy may significantly improve survival for selected patients with peritoneal surface malignancies, but it has always been criticized due to the high incidence of...
8.
Faviana P, Boldrini L, Gronchi L, Galli L, Erba P, Gentile C, et al.
Int J Behav Med
. 2022 Dec;
30(6):836-848.
PMID: 36459332
Background: Tumors develop within an organism operating in a specific social and physical environment. Cortisol and dehydroepiandrosterone (DHEA), two of the most abundant steroid hormones in humans, are involved in...
9.
Gadducci A, Cosio S, Lippolis P
Anticancer Res
. 2022 Oct;
42(10):4659-4665.
PMID: 36191972
Hyperthermic intraperitoneal chemotherapy (HIPEC) has been widely investigated in patients with peritoneal carcinomatosis, including those with epithelial ovarian cancer (EOC), with conflicting results. The hyperthermia enhances drug tissue penetration, synergizes...
10.
Faviana P, Boldrini L, Gentile C, Erba P, Sammarco E, Bartoli F, et al.
Diagnostics (Basel)
. 2022 Aug;
12(8).
PMID: 36010311
Introduction: Studies have shown that the Ki-67 index is a valuable biomarker for the diagnosis, and classification of gastro-entero-pancreatic neuroendocrine tumors (GEP-NETs). We re-evaluated the expression of Ki-67 based on...